Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study

BACKGROUND: A serogroup A meningococcal polysaccharide–tetanus toxoid conjugate vaccine (PsA–TT, MenAfriVac) was licensed in India in 2009, and pre-qualified by WHO in 2010, on the basis of its safety and immunogenicity. This vaccine is now being deployed across the African meningitis belt. We studi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Daugla, DM, Gami, JP, Gamougam, K, Naibei, N, Mbainadji, L, Narbé, M, Toralta, J, Kodbesse, B, Ngadoua, C, Coldiron, ME, Fermon, F, Page, A-L, Djingarey, MH, Hugonnet, S, Harrison, OB, Rebbetts, LS, Tekletsion, Y, Watkins, ER, Hill, D, Caugant, DA, Chandramohan, D, Hassan-King, M, Manigart, O, Nascimento, M, Woukeu, A, Trotter, C, Stuart, JM, Maiden, MCJ, Greenwood, BM
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2013
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898950/
https://ncbi.nlm.nih.gov/pubmed/24035220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(13)61612-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares